Opposing effects of glucocorticoids and Wnt signaling on Krox20 and mineral deposition in osteoblast cultures

Journal of Cellular Biochemistry

Volumn 103, Issue 6, 2008, Pages 1938-1951

  Leclerc, Nathalie ^a   Noh, Tommy ^a   Cogan, Jon ^a   Samarawickrama, Dilan B ^a   Smith, Elisheva ^a   Frenkel, Baruch ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Early growth response genes; Glucocorticoids; Krox20; Mineralization; Osteoblast; Wnt signaling

Indexed keywords

DEXAMETHASONE; EARLY GROWTH RESPONSE FACTOR 2; WNT PROTEIN;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CELL CULTURE; CELL CYCLE ARREST; CELL STIMULATION; CELL STRAIN 3T3; CORTICOSTEROID INDUCED OSTEOPOROSIS; DEVELOPMENTAL STAGE; DRUG INHIBITION; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 2; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; MICE; OSTEOBLASTS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 41849099277     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21587     Document Type: Article

References (71)

1. Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F. 2003. High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18:960-974.
2. Banerjee C, Hiebert SW, Stein JL, Lian JB, Stein GS. 1996. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci USA 93:4968-4973.
3. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513-1521.
4. Canalis E. 2005. Mechanisms of glucocorticoid action in bone. Curr Osteoporos Rep 3:98-102.
5. Cenci S, Weitzmann MN, Gentile MA, Aisa MC, Pacifici R. 2000. M-CSF neutralization and egr-1 deficiency prevent ovariectomy-induced bone loss. J Clin Invest 105:1279-1287.
6. Chavrier P, Zerial M, Lemaire P, Almendral J, Bravo R, Charnay P. 1988. A gene encoding a protein with zinc fingers is activated during G0/G1 transition in cultured cells. EMBO J 7:29-35.
7. Chavrier P, Vesque C, Galliot B, Vigneron M, Dolle P, Duboule D, Charnay P. 1990. The segment-specific gene Krox-20 encodes a transcription factor with binding sites in the promoter region of the Hox-1.4 gene. EMBO J 9:1209-1218.
8. Chen Z, Torrens JI, Anand A, Spiegelman BM, Friedman JM. 2005. Krox20 stimulates adipogenesis via C/EBP-beta-dependent and -independent mechanisms. Cell Metab 1:93-106.
9. Christy BA, Lau LF, Nathans D. 1988. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc Natl Acad Sci USA 85:7857-7861.
10. de Boer J, Siddappa R, Gaspar C, van Apeldoorn A, Fodde R, van Blitterswijk C. 2004. Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 34:818-826.
11. Delany AM, Durant D, Canalis E. 2001. Glucocorticoid suppression of IGF I transcription in osteoblasts. Mol Endocrinol 15:1781-1789.
12. Ducy P, Karsenty G. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-1869.
13. Fang MA, Noguchi GM, McDougall S. 1996. Prostaglandin E2 induces Egr-1 mRNA in MC3T3-E1 osteoblastic cells by a protein kinase C-dependent pathway. Prostaglandins Leukot Essent Fatty Acids 54:109-114.
14. Frenkel B, Montecino M, Green J, Aslam F, Desai R, Banerjee C, Stein JL, Lian JB, Stein GS. 1996. Basal and vitamin D-responsive activity of the rat osteocalcin promoter in stably transfected osteosarcoma cells: Requirement of upstream sequences for control by the proximal regulatory domain. Endocrinology 137:1080-1088.
15. Galera P, Musso M, Ducy P, Karsenty G. 1994. c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. Proc Natl Acad Sci USA 91:9372-9376.
16. Galera P, Park RW, Ducy P, Mattei MG, Karsenty G. 1996. c-Krox binds to several sites in the promoter of both mouse type I collagen genes. Structure/function study and developmental expression analysis. J Biol Chem 271:21331-21339.
17. Gashler A, Sukhatme VP. 1995. Early growth response protein 1 (Egr-1): Prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol 50:191-224.
18. Gillian AL, Svaren J. 2004. The Ddx20/DP103 dead box protein represses transcriptional activation by Egr2/Krox-20. J Biol Chem 279:9056-9063.
19. Glass DA 2nd, Karsenty G. 2006. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway. Curr Top Dev Biol 73:43-84.
20. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML. 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523.
21. Hass R, Brach M, Gunji H, Kharbanda S, Kufe D. 1992. Inhibition of EGR-1 and NF-kappa B gene expression by dexamethasone during phorbol ester-induced human monocytic differentiation. Biochem Pharmacol 44:1569-1576.
22. Jia D, O'Brien CA, Stewart SA, Manolagas SC, Weinstein RS. 2006. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147:5592-5599.
23. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA II, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L. 2002. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303-314.
24. Kharbanda S, Nakamura T, Stone R, Hass R, Bernstein S, Datta R, Sukhatme VP, Kufe D. 1991. Expression of the early growth response 1 and 2 zinc finger genes during induction of monocytic differentiation. J Clin Invest 88:571-577.
25. Kim HJ, Zhao H, Kitaura H, Bhattacharyya S, Brewer JA, Muglia LJ, Ross FP, Teitelbaum SL. 2006. Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 116:2152-2160.
26. Leclerc N, Luppen CA, Ho VV, Nagpal S, Hacia JG, Smith E, Frenkel B. 2004. Gene expression profiling of glucocorticoid-inhibited osteoblasts. J Mol Endocrinol 33:175-193.
27. Leclerc N, Noh T, Khokhar A, Smith E, Frenkel B. 2005. Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer. Arthritis Rheum 52:929-939.
28. Lee SL, Sadovsky Y, Swirnoff AH, Polish JA, Goda P, Gavrilina G, Milbrandt J. 1996. Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 273:1219-1221.
29. Lemaire P, Revelant O, Bravo R, Charnay P. 1988. Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc Natl Acad Sci USA 85:4691-4695.
30. Levi G, Topilko P, Schneider-Maunoury S, Lasagna M, Mantero S, Cancedda R, Charnay P. 1996. Defective bone formation in Krox-20 mutant mice. Development 122:113-120.
31. Li X, Liu P, Liu W, Maye P, Zhang J, Zhang Y, Hurley M, Guo C, Boskey A, Sun L, Harris SE, Rowe DW, Ke HZ, Wu D. 2005. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet 37:945-952.
32. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML. 2002. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11-19.
33. Luciano RL, Wilson AC. 2003. HCF-1 functions as a coactivator for the zinc finger protein Krox20. J Biol Chem 278:51116-51124.
34. Luppen CA, Leclerc N, Noh T, Barski A, Khokhar A, Boskey AL, Smith E, Frenkel B. 2003a. Brief bone morphogenetic protein 2 treatment of glucocorticoid-inhibited MC3T3-E1 osteoblasts rescues commitment-associated cell cycle and mineralization without alteration of Runx2. J Biol Chem 278:44995-45003.
35. Luppen CA, Smith E, Spevak L, Boskey AL, Frenkel B. 2003b. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J Bone Miner Res 18:1186-1197.
36. Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A. 2006. Glucocorticoid-induced osteoporosis: An update. Trends Endocrinol Metab 17:144-149.
37. Miguel SM, Namdar-Attar M, Noh T, Frenkel B, Bab I. 2005. ERK1/2-activated de novo Mapkapk2 synthesis is essential for osteogenic growth peptide mitogenic signaling in osteoblastic cells. J Biol Chem 280:37495-37502.
38. Milbrandt J. 1987. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238:797-799.
39. Mittelstadt PR, Ashwell JD. 2001. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 276:29603-29610.
40. Molnar G, Crozat A, Pardee AB. 1994. The immediate-early gene Egr-1 regulates the activity of the thymidine kinase promoter at the G0-to-G1 transition of the cell cycle. Mol Cell Biol 14:5242-5248.
41. Nonchev S, Maconochie M, Vesque C, Aparicio S, Ariza-McNaughton L, Manzanares M, Maruthainar K, Kuroiwa A, Brenner S, Charnay P, Krumlauf R. 1996. The conserved role of Krox-20 in directing Hox gene expression during vertebrate hindbrain segmentation. Proc Natl Acad Sci USA 93:9339-9345.
42. O'Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS. 2004. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145:1835-1841.
43. O'Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM. 1999. The EGR family of transcription-regulatory factors: Progress at the interface of molecular and systems neuroscience. Trends Neurosci 22:167-173.
44. Ohnaka K, Taniguchi H, Kawate H, Nawata H, Takayanagi R. 2004. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: Novel mechanism of glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun 318:259-264.
45. Ohnaka K, Tanabe M, Kawate H, Nawata H, Takayanagi R. 2005. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem Biophys Res Commun 329:177-181.
46. Parkinson DB, Bhaskaran A, Droggiti A, Dickinson S, D'Antonio M, Mirsky R, Jessen KR. 2004. Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death. J Cell Biol 164:385-394.
47. Pereira RM, Delany AM, Durant D, Canalis E. 2002. Cortisol regulates the expression of Notch in osteoblasts. J Cell Biochem 85:252-258.
48. Petersohn D, Schoch S, Brinkmann DR, Thiel G. 1995. The human synapsin II gene promoter. Possible role for the transcription factor zif268/egr-1, polyoma enhancer activator 3, and AP2. J Biol Chem 270:24361-24369.
49. Russo MW, Sevetson BR, Milbrandt J. 1995. Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc Natl Acad Sci USA 92:6873-6877.
50. Schneider-Maunoury S, Topilko P, Seitandou T, Levi G, Cohen-Tannoudji M, Pournin S, Babinet C, Charnay P. 1993. Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell 75:1199-1214.
51. Smith E, Frenkel B. 2005. Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner. J Biol Chem 280:2388-2394.
52. Smith E, Redman RA, Logg CR, Coetzee GA, Kasahara N, Frenkel B. 2000. Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes. J Biol Chem 275:19992-20001.
53. Smith E, Coetzee GA, Frenkel B. 2002. Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta. J Biol Chem 277:18191-18197.
54. Suva LJ, Ernst M, Rodan GA. 1991. Retinoic acid increases zif268 early gene expression in rat preosteoblastic cells. Mol Cell Biol 11:2503-2510.
55. Svaren J, Sevetson BR, Apel ED, Zimonjic DB, Popescu NC, Milbrandt J. 1996. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol Cell Biol 16:3545-3553.
56. Swirnoff AH, Milbrandt J. 1995. DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol Cell Biol 15:2275-2287.
57. Thiel G, Cibelli G. 2002. Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193:287-292.
58. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, Babinet C, Charnay P. 1994. Krox-20 controls myelination in the peripheral nervous system. Nature 371:796-799.
59. Topilko P, Schneider-Maunoury S, Levi G, Trembleau A, Gourdji D, Driancourt MA, Rao CV, Charnay P. 1998. Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice. Mol Endocrinol 12:107-122.
60. Tourtellotte WG, Milbrandt J. 1998. Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. Nat Genet 20:87-91.
61. Tourtellotte WG, Nagarajan R, Auyeung A, Mueller C, Milbrandt J. 1999. Infertility associated with incomplete spermatogenic arrest and oligozoospermia in Egr4-deficient mice. Development 126:5061-5071.
62. van der Horst G, van der Werf SM, Farih-Sips H, van Bezooijen RL, Lowik CW, Karperien M. 2005. Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells. J Bone Miner Res 20:1867-1877.
63. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. 2000. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000.
64. Voiculescu O, Charnay P, Schneider-Maunoury S. 2000. Expression pattern of a Krox-20/Cre knock-in allele in the developing hindbrain, bones, and peripheral nervous system. Genesis 26:123-126.
65. Wang FS, Lin CL, Chen YJ, Wang CJ, Yang KD, Huang YT, Sun YC, Huang HC. 2005. Secreted frizzled-related protein 1 modulates glucocorticoid attenuation of osteogenic activities and bone mass. Endocrinology 146:2415-2423.
66. Warner LE, Mancias P, Butler IJ, McDonald CM, Keppen L, Koob KG, Lupski JR. 1998. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 18:382-384.
67. Westendorf JJ, Kahler RA, Schroeder TM. 2004. Wnt signaling in osteoblasts and bone diseases. Gene 341:19-39.
68. Wilkinson DG, Bhatt S, Chavrier P, Bravo R, Charnay P. 1989. Segment-specific expression of a zinc-finger gene in the developing nervous system of the mouse. Nature 337:461-464.
69. Zalavras C, Shah S, Birnbaum MJ, Frenkel B. 2003. Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis. Crit Rev Eukaryot Gene Expr 13:221-235.
70. Zhao M, Qiao M, Oyajobi BO, Mundy GR, Chen D. 2003. E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem 278:27939-27944.
71. Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G. 1996. The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci 8:129-145.